HCA Healthcare (HCA) Projected to Post Quarterly Earnings on Tuesday

by · The Cerbat Gem

HCA Healthcare (NYSE:HCA – Get Free Report) will likely be issuing its Q3 2026 results before the market opens on Tuesday, October 27th. Analysts expect HCA Healthcare to post earnings of $6.65 per share and revenue of $19.33 billion for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Tuesday, October 27, 2026 at 10:00 AM ET.

HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the business earned $6.84 earnings per share. On average, analysts expect HCA Healthcare to post $29.51 EPS for the current fiscal year and $32.04 EPS for the next fiscal year.

HCA Healthcare Stock Up 0.1%

Shares of HCA opened at $469.45 on Monday. The firm has a market capitalization of $101.64 billion, a PE ratio of 15.72, a P/E/G ratio of 1.58 and a beta of 1.10. The firm has a 50-day moving average price of $431.58 and a 200 day moving average price of $418.51. HCA Healthcare has a 52-week low of $353.99 and a 52-week high of $556.52.

Analyst Ratings Changes

A number of analysts have recently weighed in on HCA shares. Truist Financial reduced their price target on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Weiss Ratings upgraded shares of HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Mizuho dropped their target price on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a report on Tuesday, July 28th. Robert W. Baird cut their target price on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a research report on Monday, July 27th. Finally, Royal Bank Of Canada increased their price target on HCA Healthcare from $435.00 to $496.00 and gave the company an “outperform” rating in a research note on Wednesday, October 7th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $467.61.

View Our Latest Research Report on HCA Healthcare

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

  • Positive Sentiment: Attractive valuation: Zacks identifies HCA as a strong value stock, which may appeal to investors seeking a relatively inexpensive healthcare company with potential for market-beating returns. Here’s Why HCA Healthcare Is a Strong Value Stock
  • Positive Sentiment: Defensive investor interest: A broader rotation toward high-quality, defensive companies in healthcare and other essential sectors could provide a supportive backdrop for HCA stock. Defensive Rotation Toward Quality Companies
  • Positive Sentiment: Expansion in Florida: Cape Coral approved $31 million in incentives for a planned $300 million HCA hospital, supporting the company’s long-term market expansion and future capacity. Cape Coral Approves Incentives for HCA Hospital
  • Neutral Sentiment: Upcoming earnings catalyst: HCA is scheduled to report third-quarter results around October 27. Investors are focused on admissions, occupancy, inpatient revenue and other operating metrics, with the report likely to determine the stock’s next significant move. HCA Third-Quarter Earnings Preview
  • Neutral Sentiment: Workforce investment: HCA opened a clinical training center in Gainesville, which may strengthen its healthcare staffing pipeline but is unlikely to materially affect near-term earnings. HCA Opens Clinical Training Center
  • Negative Sentiment: Mixed earnings outlook: Higher admissions, occupancy and inpatient revenue could help third-quarter results, but rising costs and fewer outpatient surgeries may pressure margins and temper investor expectations. Will HCA Earnings Benefit From Higher Admissions?

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

Read More